The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,051,008 in first-year total cost, median $2,056,909.
Most frequent study sections
- Neurological Sciences and Disorders C Study Section[NSD-C]2
- Special Emphasis Panel[ZNS1 SRB-C (07)]1
- Special Emphasis Panel[ZNS1 SRB-S (01)]1
- Special Emphasis Panel[ZNS1 SRB-S (02)]1
Most frequent institutions
- CARNEGIE-MELLON UNIVERSITY1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
- STANFORD UNIVERSITY1
- UNIVERSITY OF CALIFORNIA, SAN DIEGO1
- YALE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Advancing epilepsy diagnosis with flexible, high-resolution thin-film electrodes1UG3NS120172-01A1 | FRANKLIN, ROBERT KYLEFRIEDMAN, DANIELPESARAN, BIJANSOLZBACHER, FLORIANVIVENTI, JONATHAN | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $1,838,946 | NSD |
| 2021 | Clinical Translation of Targeted and Noninvasive Ultrasonic Propofol Uncaging1UG3NS114438-01 | AIRAN, RAAG D | STANFORD UNIVERSITY, CA | $3,833,148 | ZNS1 |
| 2021 | Thin, High-Density, High-Performance, Depth and Surface Microelectrodes for Diagnosis and Treatment of Epilepsy1UG3NS123723-01 | DAYEH, SHADI | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $2,364,802 | NSD |
| 2021 | SWITCH trial: Early feasibility study of Stentrode BCI for augmentative communication1UG3NS120191-01 | OPIE, NICHOLAS LACHLANOXLEY, THOMAS JPUTRINO, DAVID FRANCISWEBER, DOUGLAS J | CARNEGIE-MELLON UNIVERSITY, PA | $2,056,909 | ZNS1 |
| 2019 | Thalamic stimulation to prevent impaired consciousness in epilepsy1UG3NS112826-01 | BLUMENFELD, HAL | YALE UNIVERSITY, CT | $957,203 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.